BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 943151)

  • 1. Use of a passive hemagglutination inhibition test for monitoring levels of serum carcinoembryonic antigen following surgical therapy.
    Anthony RL; Sosnowski KM
    Ann Clin Lab Sci; 1976; 6(2):130-6. PubMed ID: 943151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The CEA test and other immunological tests as disease course controls in gastrointestinal adenocarcinoma].
    Hasler E; Spengler A; Berchtold R; Brunner KW; de Weck A
    Schweiz Med Wochenschr; 1977 Nov; 107(47):1683-91. PubMed ID: 929129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoembryonic antigen (CEA). A prospective clinical trail in patients with gastrointestinal cancer.
    Kjaer M; Fischerman K
    Scand J Gastroenterol Suppl; 1976; 37():99-106. PubMed ID: 1064149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carcinoembryonic antigen in serum and the tissue of patients with colon cancer].
    Odagiri E; Jibiki K; Shinozaki H; Nakamura S; Demura R; Demura H; Suzuki H
    Gan No Rinsho; 1984 Oct; 30(13):1680-5. PubMed ID: 6513021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical usefulness of CEA assay.
    Luporini G; Mangiarotti F; Fraschini P; Labianca R; Tassi GC; De Barbieri A
    Boll Ist Sieroter Milan; 1976; 55(2):151-63. PubMed ID: 1023883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viroimmunoassay utilizing a synthetic peptide: a test equivalent to the carcinoembryonic antigen radioimmunoassay.
    Arnon R; Novik N; Haimovich J; Chaitchik S
    Isr J Med Sci; 1977 Oct; 13(10):1022-7. PubMed ID: 591295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
    Tappero G; Piantino P; Cerchier A; Pecchio F
    Minerva Med; 1985 Apr; 76(16):765-70. PubMed ID: 2582313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The carcinoembryonic antigen in malignancies of the gastrointestinal tract].
    Auer IO
    Z Gastroenterol; 1977 Sep; 15(9):543-52. PubMed ID: 906602
    [No Abstract]   [Full Text] [Related]  

  • 9. Preliminary immunologic characterization of glycoprotein antigens (CEA) of tumors of gastrointestinal tract in humans.
    Harlozińska A; Zawadzka H; Woźniewski A; Richter R
    Arch Immunol Ther Exp (Warsz); 1975; 23(2):247-55. PubMed ID: 50054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CEA levels in fluids bathing gastrointestinal tumors.
    Molnar IG; Vandevoorde JP; Gitnick GL
    Gastroenterology; 1976 Apr; 70(4):513-5. PubMed ID: 1254136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of M43: a novel cancer-associated mucin epitope.
    Goodgame R; Kiefe C; Rose E; Sutton F; Brown J; Alpert E
    Cancer Res; 1993 Jun; 53(12):2803-9. PubMed ID: 7684947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue carcinoembryonic antigen, dysplasia, and disease duration in colonic inflammatory bowel disease.
    Greenstein AJ; Panvelliwalla DK; Katz LB; Heimann TM; Donnelly J; Pertsimlidis D; Geller S; Smith H; Aufses AH
    Am J Gastroenterol; 1982 Apr; 77(4):212-5. PubMed ID: 7072691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of carcinoembryonic antigen in tissue and serum with grade and stage of colon cancer.
    Bhatnagar J; Tewari HB; Bhatnagar M; Austin GE
    Anticancer Res; 1999; 19(3B):2181-7. PubMed ID: 10472328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum.
    Lunde OC; Havig O
    Acta Chir Scand; 1982; 148(2):189-93. PubMed ID: 7148317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells.
    Hampton R; Walker M; Marshall J; Juhl H
    Oncogene; 2002 Nov; 21(51):7817-23. PubMed ID: 12420218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Using CEA for diagnostic, therapeutic and prognostic evaluation in colorectal cancers].
    Terabe K; Ichihashi H; Kamei H; Kondo T
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):111-6. PubMed ID: 6696454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-carcinoembryonic antigen sera acquiring higher tumor specificity by absorption with a plasma factor.
    Bartorelli A; Bailo M; Gugliotta P; Biancardi C; Botta M; Fulcheri E; Cavalca V; Ferrara R; Bussolati G
    Biomed Pharmacother; 1985; 39(8):433-41. PubMed ID: 3914913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of carcinoembryonic antigen in serum of patients by using a technique of passive hemagglutination inhibition.
    Anthony RL; Sosnowski KM
    Clin Immunol Immunopathol; 1975 Sep; 4(3):362-73. PubMed ID: 1192614
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of an isomeric species of carcinoembryonic antigen with neoplasia of the gastrointestinal tract.
    Edgington TS; Astarita RW; Plow EF
    N Engl J Med; 1975 Jul; 293(3):103-7. PubMed ID: 166311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.